433 related articles for article (PubMed ID: 32678959)
1. IL-1β/IL-1R1 signaling induced by intranasal lipopolysaccharide infusion regulates alpha-Synuclein pathology in the olfactory bulb, substantia nigra and striatum.
Niu H; Wang Q; Zhao W; Liu J; Wang D; Muhammad B; Liu X; Quan N; Zhang H; Zhang F; Wang Y; Li H; Yang R
Brain Pathol; 2020 Nov; 30(6):1102-1118. PubMed ID: 32678959
[TBL] [Abstract][Full Text] [Related]
2. Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson's Disease in C57BL/6 Mice.
Deng I; Corrigan F; Garg S; Zhou XF; Bobrovskaya L
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299000
[TBL] [Abstract][Full Text] [Related]
3. Environmental neurotoxic challenge of conditional alpha-synuclein transgenic mice predicts a dopaminergic olfactory-striatal interplay in early PD.
Nuber S; Tadros D; Fields J; Overk CR; Ettle B; Kosberg K; Mante M; Rockenstein E; Trejo M; Masliah E
Acta Neuropathol; 2014 Apr; 127(4):477-94. PubMed ID: 24509835
[TBL] [Abstract][Full Text] [Related]
4. IL-1β/IL-1R1 signaling is involved in the propagation of α-synuclein pathology of the gastrointestinal tract to the brain.
Muhammad B; Li H; Gu Y; Xue S; Gao Y; Xu Z; Fang X; Ding H; Wu F; Geng D; Niu H
J Neurochem; 2023 Sep; 166(5):830-846. PubMed ID: 37434423
[TBL] [Abstract][Full Text] [Related]
5. Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration.
Paumier KL; Luk KC; Manfredsson FP; Kanaan NM; Lipton JW; Collier TJ; Steece-Collier K; Kemp CJ; Celano S; Schulz E; Sandoval IM; Fleming S; Dirr E; Polinski NK; Trojanowski JQ; Lee VM; Sortwell CE
Neurobiol Dis; 2015 Oct; 82():185-199. PubMed ID: 26093169
[TBL] [Abstract][Full Text] [Related]
6. Intranasal Exposure to Low-Dose Rotenone Induced Alpha-Synuclein Accumulation and Parkinson's Like Symptoms Without Loss of Dopaminergic Neurons.
Sharma M; Kaur J; Rakshe S; Sharma N; Khunt D; Khairnar A
Neurotox Res; 2022 Feb; 40(1):215-229. PubMed ID: 34817799
[TBL] [Abstract][Full Text] [Related]
7. Minocycline inhibition of microglial rescues nigrostriatal dopaminergic neurodegeneration caused by mutant alpha-synuclein overexpression.
Wang Y; Wang Q; Yu R; Zhang Q; Zhang Z; Li H; Ren C; Yang R; Niu H
Aging (Albany NY); 2020 Jul; 12(14):14232-14243. PubMed ID: 32706757
[TBL] [Abstract][Full Text] [Related]
8. Alpha-synuclein overexpression in the olfactory bulb initiates prodromal symptoms and pathology of Parkinson's disease.
Niu H; Shen L; Li T; Ren C; Ding S; Wang L; Zhang Z; Liu X; Zhang Q; Geng D; Wu X; Li H
Transl Neurodegener; 2018; 7():25. PubMed ID: 30356861
[TBL] [Abstract][Full Text] [Related]
9. Perturbation of in vivo Neural Activity Following α-Synuclein Seeding in the Olfactory Bulb.
Kulkarni AS; Del Mar Cortijo M; Roberts ER; Suggs TL; Stover HB; Pena-Bravo JI; Steiner JA; Luk KC; Brundin P; Wesson DW
J Parkinsons Dis; 2020; 10(4):1411-1427. PubMed ID: 32925105
[TBL] [Abstract][Full Text] [Related]
10. Dose-related biphasic effect of the Parkinson's disease neurotoxin MPTP, on the spread, accumulation, and toxicity of α-synuclein.
Merghani MM; Ardah MT; Al Shamsi M; Kitada T; Haque ME
Neurotoxicology; 2021 May; 84():41-52. PubMed ID: 33549656
[TBL] [Abstract][Full Text] [Related]
11. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Rho-kinase by Fasudil protects dopamine neurons and attenuates inflammatory response in an intranasal lipopolysaccharide-mediated Parkinson's model.
He Q; Li YH; Guo SS; Wang Y; Lin W; Zhang Q; Wang J; Ma CG; Xiao BG
Eur J Neurosci; 2016 Jan; 43(1):41-52. PubMed ID: 26565388
[TBL] [Abstract][Full Text] [Related]
13. Microglia affect α-synuclein cell-to-cell transfer in a mouse model of Parkinson's disease.
George S; Rey NL; Tyson T; Esquibel C; Meyerdirk L; Schulz E; Pierce S; Burmeister AR; Madaj Z; Steiner JA; Escobar Galvis ML; Brundin L; Brundin P
Mol Neurodegener; 2019 Aug; 14(1):34. PubMed ID: 31419995
[TBL] [Abstract][Full Text] [Related]
14. Single-dose intranasal administration of α-syn PFFs induce lewy neurite-like pathology in olfactory bulbs.
Sawamura M; Ohira J; Hikawa R; Ishimoto T; Nakanishi E; Yamakado H; Takahashi R
Parkinsonism Relat Disord; 2023 Jul; 112():105440. PubMed ID: 37267818
[TBL] [Abstract][Full Text] [Related]
15. α-Synuclein Pathology and Reduced Neurogenesis in the Olfactory System Affect Olfaction in a Mouse Model of Parkinson's Disease.
Martin-Lopez E; Vidyadhara DJ; Liberia T; Meller SJ; Harmon LE; Hsu RM; Spence N; Brennan B; Han K; Yücel B; Chandra SS; Greer CA
J Neurosci; 2023 Feb; 43(6):1051-1071. PubMed ID: 36596700
[TBL] [Abstract][Full Text] [Related]
16. Widespread transneuronal propagation of α-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson's disease.
Rey NL; Steiner JA; Maroof N; Luk KC; Madaj Z; Trojanowski JQ; Lee VM; Brundin P
J Exp Med; 2016 Aug; 213(9):1759-78. PubMed ID: 27503075
[TBL] [Abstract][Full Text] [Related]
17. Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease.
Gao HM; Zhang F; Zhou H; Kam W; Wilson B; Hong JS
Environ Health Perspect; 2011 Jun; 119(6):807-14. PubMed ID: 21245015
[TBL] [Abstract][Full Text] [Related]
18. Alpha-synuclein aggregation alters tyrosine hydroxylase phosphorylation and immunoreactivity: lessons from viral transduction of knockout mice.
Alerte TN; Akinfolarin AA; Friedrich EE; Mader SA; Hong CS; Perez RG
Neurosci Lett; 2008 Apr; 435(1):24-9. PubMed ID: 18314273
[TBL] [Abstract][Full Text] [Related]
19. Lewy Body Disease Primate Model with α-Synuclein Propagation from the Olfactory Bulb.
Sawamura M; Onoe H; Tsukada H; Isa K; Yamakado H; Okuda S; Ikuno M; Hatanaka Y; Murayama S; Uemura N; Isa T; Takahashi R
Mov Disord; 2022 Oct; 37(10):2033-2044. PubMed ID: 35989519
[TBL] [Abstract][Full Text] [Related]
20. α-Synuclein Propagation Mouse Models of Parkinson's Disease.
Uemura N; Ueda J; Okuda S; Sawamura M; Takahashi R
Methods Mol Biol; 2021; 2322():119-130. PubMed ID: 34043198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
